Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01132053 · ClinicalTrials.gov registry record
Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 126
- Enrollment target
NCT01132053: Completed study, sponsored by Beth Israel Deaconess Medical Center.
NCT01132053 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01132053 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2004-06 |
| Est. Completion | 2018-12 |
What the finished NCT01132053 record still lists
NCT01132053 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01132053 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01132053 about?
NCT01132053 is a clinical study titled "Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)". This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.
What is the current status of trial NCT01132053?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2004-06. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01132053?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia